People wasting billions of dollars on 'quack' health food products

Nov 26, 2008

Globally every year, obese people waste billions of pounds on food products that 'imply' that they aid weight loss, but are totally ineffective, says a nutritional expert on bmj.com today.

Professor Lean from the University of Glasgow, is hopeful that a new European Union (EU) Directive on Unfair Commercial Practices, adopted this year in UK, will finally protect vulnerable consumers who are tricked into to buying useless food products or supplements in attempts to combat their disease.

Unlike medicines, food products that are marketed for health reasons are not subject to the same stringent research trials and control, and consumers are often misled.

It is already illegal for unsubstantiated claims to be made about the composition or nutritional function of food products, eg. that they are low in fat, high in fibre or help lower cholesterol, and it is also illegal to claim that a food can treat or prevent any disease—including obesity. However, many unsubstantiated health claims are still made, or implied. Misleading marketing can be found within brand names and images on packaging, in shelf or shop names, or on websites which suggest that products help weight control, are slimming, or are "Health Foods", when there is no evidence.

Lean is concerned that obese people have been fooled into parting with billions of pounds every year on products that cannot help them. In 2000, people in the US spent $35bn (£22bn) on weight loss products, many of them making false and unsubstantiated claims.

The "commercial exploitation of vulnerable patients with quack medicines" will hopefully be brought to an end with the introduction of the new EU directive, say Lean. However, the laws need to be enforced proactively to enable doctors and consumers to move towards managing diseases confidently with evidence based treatment and diet programmes.

He points out that, of all the hundreds of products currently on sale to help people lose weight, only energy-restricted diets and exercise, the drugs orlistat and sibutramine, and in some cases bariatric surgery, are safe, effective and cost-effective. The remainder, he says, are either not effective or not safe.

The new regulations "may even help with the bigger battle to prevent obesity, by prohibiting advertisements across the EU that encourage children to buy energy dense products or to pester their parents to buy them", he adds.

Source: British Medical Journal

Explore further: FTC clears Sun Pharma's $4B purchase of competitor Ranbaxy

add to favorites email to friend print save as pdf

Related Stories

How to raise tasty cannibal crabs

Jan 30, 2015

Do you like eating crabs? In Jakarta, enjoying the tasty crustaceans has become a hot trend, as more restaurants with names like The Holy Crab and Cut the Crab open up. Crabs are delicious delicacies, great ...

Recommended for you

Why aren't there any human doctors in Star Wars?

Jan 30, 2015

Though set "a long time ago in a galaxy far, far away," it isn't hard to see in the Star Wars films a vision of our own not so distant future. But Anthony Jones, a physician with a long background in health ...

Cambodia bans 'virgin surgery' adverts

Jan 29, 2015

The Cambodian government has ordered a hospital to stop advertising so-called virginity restoration procedures, saying it harms the "morality" of society.

What's happening with your donated specimen?

Jan 28, 2015

When donating blood, plasma, human tissue or any other bodily sample for medical research, most people might not think about how it's being used. But if you were told, would you care?

Amgen tops Street 4Q forecasts

Jan 27, 2015

Amgen Inc. cruised to a 27 percent jump in fourth-quarter profit and beat Wall Street expectations, due to higher sales of nearly all its medicines, tight cost controls and a tax benefit.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.